Pharmaceuticals for Women's Health, Industry Forecast to 2025 - Includes Profiles of Leading Players AbbVie, Bayer, Daiichi Sankyo Co, Eli Lilly and Co, Johnson & Johnson and Merck
DUBLIN, Aug. 26, 2020 /PRNewswire/ -- The "Pharmaceuticals for Women's Health: Global Markets" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
While women's health encompasses several health issues, this report will focus on menopause-related disorders, postmenopausal osteoporosis, endometriosis, polycystic ovarian syndrome and pregnancy disorders.
The report includes:
-- Detailed overview of the global markets for pharmaceuticals for women's
health and identification of the main women's health disorders
-- Analyses of market trends, with data from 2019, estimates for 2020 and
projections of compound annual growth rates (CAGRs) through 2025
-- Evaluation of the impact of demographic, economic and other factors that
will drive future demand in the women's health therapeutics market
-- A look at the unmet needs in women's health therapeutics and details of
the promising new drugs and therapies that are still in development and
testing stage
-- Market forecast of the potential drugs in the pipeline, information on
late-stage pipeline drugs and overview of osteoporosis drug development
-- Insights into government concerns and initiatives towards women's health
-- Highlights of current and future market potential and a detailed
analysis of the current market size, and regulatory scenarios
-- Market share analysis of leading drug manufacturers and detailed
coverage of women's health therapeutics industry in terms of different
events like mergers and acquisitions, agreements, collaborations, and
partnerships
-- Company profiles of the leading suppliers of the industry including
AbbVie Inc., Bayer AG, Daiichi Sankyo Co. Ltd., Eli Lilly and Co.,
Johnson & Johnson Inc. and Merck KGaA
Key Topics Covered
Chapter 1 Introduction
-- Study Goals and Objectives
-- Reasons for Doing This Study
-- Scope of Report
-- Information Sources
-- Methodology
-- Geographic Breakdown
Chapter 2 Summary and Highlights
Chapter 3 Technologies and Global Markets Overview
-- Disease Overview and Definitions
-- Market Driving Factors and Opportunities
-- Aging Female Population
-- Government Involvement and Increased Funding
-- Increasing Awareness Regarding Women's Disorders and Treatments
-- Market Restraints
-- Poor Diagnosis
-- Availability of Alternate Treatment Options and Lifestyle Changes
-- Unavailability of Novel Treatments
-- High Cost of Treatment
Chapter 4 Pipeline Assessment and Analysis
-- Drugs in the Pipeline
-- Overview of Osteoporosis Drug Development Pipeline
-- Late-Stage Pipeline Drugs
-- Relugolix (Myovant Sciences)
-- Proellex (Repros Therapeutics)
Chapter 5 Regulatory Structure
-- Overview of Regulations
-- United States
-- Canada
-- Europe
-- Japan
-- Overview of Pricing and Reimbursement
-- United States
-- Canada
-- Europe
-- Japan
Chapter 6 Market Breakdown by Women's Health Condition, Disorder and Disease
-- Introduction
-- Menopause
-- Overview
-- Symptoms
-- Risk Factors
-- Epidemiology and Economic Burden
-- Diagnosis
-- Treatments
-- Market Size and Forecasts
-- Postmenopausal Osteoporosis
-- Overview
-- Epidemiology and Economic Burden
-- Diagnosis
-- Treatments
-- Market Size and Forecasts
-- Endometriosis
-- Overview
-- Epidemiology and Economic Burden
-- Diagnosis
-- Treatments
-- Market Size and Forecasts
-- Polycystic Ovary Syndrome (PCOS)
-- Overview
-- Reducing the Risk of PCOS
-- Epidemiology and Economic Burden
-- Diagnosis
-- Treatments
-- Market Size and Forecasts
-- Pregnancy Disorders and Management
-- Overview
-- Market Size and Forecasts
-- Others
-- Overview
-- Market Size and Forecasts
Chapter 7 Market Breakdown by Region
-- Introduction
-- North America
-- United States
-- Canada
-- Mexico
-- Europe
-- United Kingdom
-- Germany
-- France
-- Spain
-- Italy
-- Rest of Europe
-- Asia-Pacific
-- China
-- Japan
-- India
-- South Korea
-- Rest of Asia-Pacific
-- South America
-- Middle East and Africa
Chapter 8 Competitive Landscape and Key Developments
-- Market Players and Strategies
-- Patent Analysis
-- Key Patents
-- Key Developments
-- Mergers and Acquisitions
-- Development of Innovative Products/Novel Product Launch
-- Agreements, Collaborations and Partnerships
-- Key Products
Chapter 9 Company Profiles
-- Abbvie Inc.
-- Allergan PLC
-- Amgen Inc.
-- Bayer AG
-- Daiichi Sankyo Co. Ltd.
-- Eli Lilly and Co.
-- Johnson & Johnson Inc.
-- Merck KGaA
-- Novo Nordisk
-- Pfizer Inc.
For more information about this report visit https://www.researchandmarkets.com/r/1sxaym
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
